EUCTR2013-003049-41-HU进行中（未招募）不适用
A Phase III, Single-center Clinical Trial to Evaluate the 4-valent HPV Vaccine for the Treatment and Prevention of Recurrent Respiratory Papillomatosis in Children
ational Institute of Child Health0 个研究点开始时间: 2013年11月4日最近更新:
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •minimum 10, max 20, otherwise healthy children, above the first year of life, with minimum 3 relapses of Recurrant Respiratory Papillomatosis could be involved
- •who underwent ear-nose-throat and oesophagoscopy examination to establish the diagnosis of RRP with or without oesophageal involvement
- •whose previously removed papillomas were pozitive for HPV 6, or 11, or both
- •who are able to mount neutralizing antibodies
- •Are the trial subjects under 18? yes
- •Number of subjects for this age range: 20
- •F.1.2 Adults (18-64 years) no
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range
排除标准
- •other chronic underlying condition,
- •other HPV type,
- •no antibody response
研究者
相似试验
进行中（未招募）
不适用
A Phase III, Randomized, Clinical Trial to Evaluate the Safety and Efficacy of the Addition of Sitagliptin in Patients With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on a Sulfonylurea in Combination With MetformiDiabetes Mellitus type 2MedDRA version: 12.1Level: LLTClassification code 10067585Term: Type 2 diabetes mellitusEUCTR2010-018318-62-HUMerck & Co., Inc.424
已完成
不适用
A phase III, single-blind trial to assess efficacy and tolerability of genital mucosa after use of product INC056ISRCTN64791295Incrementha PD&I (Brazil)65
进行中（未招募）
1 期
Phase III Randomized Controlled Trial of Pembrolizumab with or without Chemo vs Chemo in Advanced Urothelial CarcinomaAdvanced or Metastatic Urothelial CarcinomaMedDRA version: 20.0Level: LLTClassification code 10064467Term: Urothelial carcinomaSystem Organ Class: 100000004864EUCTR2015-005731-41-IEMerck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc.990
已完成
3 期
A Phase III Randomized, Controlled Clinical Trial of Pembrolizumab with or without Platinum-Based Combination Chemotherapy versus Chemotherapy in Subjects with Advanced or Metastatic Urothelial Carcinomabladder cancerNL-OMON45288Merck Sharp & Dohme (MSD)20
进行中（未招募）
1 期
Phase III Randomized Controlled Trial of Pembrolizumab with or without Chemo vs Chemo in Advanced Urothelial CarcinomaAdvanced or Metastatic Urothelial CarcinomaMedDRA version: 19.0Level: LLTClassification code 10064467Term: Urothelial carcinomaSystem Organ Class: 100000004864EUCTR2015-005731-41-ESMerck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc.990